ReviewMikrochimica acta2025
Nanoparticle-assisted strategies in mass spectrometry-based metabolite analysis: recent advances across analytical workflow.
Review in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolite analysis plays a critical role in understanding phenotypic variations, biochemical processes, and physiological responses in biological systems. Whether through untargeted metabolomic profiling or targeted approaches aimed at quantifying specific or even individual metabolites, accurate detection presents significant analytical challenges due to their vast chemical diversity, low abundance, and complexity of biological matrices. This chemical analytical process encompasses a dynamic workflow that includes sample collection, extraction, enrichment, separation, and detection. Recent advances in nanotechnology offer promising alternatives to support and enhance each stage of this workflow, particularly within mass spectrometry (MS)-based applications. Nanoparticles, due to their high surface area, tunable surface chemistry, and ability to improve sensitivity, have been widely applied to improve sample pretreatment, selective enrichment, separation efficiency, and ionization, ultimately enhancing MS-based metabolites detection. This review provides an updated overview of nanoparticle-assisted strategies throughout the MS-based metabolite analysis workflow. It discusses the different classes of those nanomaterials and their applications across various phases stages, from sample preparation to ionization and detection, supporting analyses that range from untargeted and targeted metabolomics to the detection of individual metabolites. Although the primary focus is on MS-based workflows, we also reviewed nanoparticle-assisted separation strategies coupled with alternative detection platforms, such as optical or electrochemical methods, when these approaches show potential for integration with MS workflows. This inclusion reflects the current gap in literature addressing nanoparticle-assisted separation directly coupled with MS detection systems. These cases highlight underexplored opportunities where nanomaterials could enhance separation prior to MS detection, although further work is needed to ensure compatibility with MS platforms for suitable metabolite analysis. Furthermore, we highlight emerging trends and future perspectives in this evolving field, emphasizing the potential of nanotechnology to overcome current analytical limitations and expand the scope of both metabolomic profiling and focused metabolite analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.